drugset / Trial / NCT00309049
Ixabepilone Administered as an Enteric Coated Formulation.
RandomizedCrossoverOpen-labelTreatment
Summary
The purpose of this study is to determine the pharmacokinetics of oral Ixabepilone.
Timeline
- Start
- 2006-04
- Primary completion
- 2007-05
- Completion
- 2007-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Ixabepilone | Small molecule | 15 mg | Oral |
| Comparator | Ixabepilone | Small molecule | 30 mg | Oral |
| Comparator | Ixabepilone | Small molecule | 40 mg | Oral |